Fox Advisors upgraded Amphenol from Equal Weight to Overweight and set a new price target of $85.00
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/24/2025 | $85.00 | Equal Weight → Overweight | Fox Advisors |
| 9/4/2024 | $80.00 → $71.00 | Buy → Neutral | BofA Securities |
| 7/23/2024 | $65.00 | Hold | Vertical Research |
| 5/20/2024 | $150.00 | Buy | Seaport Research Partners |
| 4/9/2024 | $125.00 | Hold | Jefferies |
| 1/5/2024 | $117.00 | Buy | Citigroup |
| 10/5/2023 | $93.00 | Outperform | Exane BNP Paribas |
| 5/19/2023 | $91.00 → $77.00 | Outperform → Neutral | Credit Suisse |
NEW YORK, July 23, 2025 /PRNewswire/ -- J.F. Lehman & Company ("JFLCO"), a leading alternative asset manager focused exclusively on the aerospace, defense, maritime, government, environmental and infrastructure sectors, announced today that investment affiliates have sold Narda AcquisitionCo., Inc. ("Narda-MITEQ" or the "Company") to Amphenol Corporation ((", Amphenol", , NYSE:APH). Terms of the transaction were not disclosed. Narda-MITEQ is a leading global designer and manufacturer of advanced radiofrequency ("RF") and microwave components and subsystems for defense and commercial e
Second Quarter 2025 Highlights: Sales of $5.7 billion, up 57% in U.S. dollars and 41% organically compared to the second quarter of 2024 GAAP Diluted EPS of $0.86, up 110% compared to prior year Adjusted Diluted EPS of $0.81, up 84% compared to prior year GAAP and Adjusted Operating Margin of 25.1% and 25.6%, respectively Operating and Free Cash Flow of $1.4 billion and $1.1 billion, respectively Acquired Narda-MITEQ in May Amphenol Corporation (NYSE:APH) today reported record second quarter 2025 results. "We are pleased to have closed the second quarter of 2025 with record sales and Adjusted Diluted EPS, both significantly exceeding the high end of our guidance," sai
Amphenol Corporation (NYSE:APH) (the "Company") announced today the pricing of its offering of €600 million aggregate principal amount of senior notes due 2032 (the "Euro Notes"). The Euro Notes will have an interest rate of 3.125% per annum. The closing of the offering of Euro Notes (the "Euro Notes Offering") is expected to occur on June 16, 2025, subject to the satisfaction of customary closing conditions. On June 9, 2025, the Company announced the pricing of its offering of $750 million aggregate principal amount of 4.375% senior notes due 2028 (the "USD Notes") by means of a separate prospectus supplement. The closing of the offering of the USD Notes (the "USD Notes Offering") is exp
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
Fox Advisors upgraded Amphenol from Equal Weight to Overweight and set a new price target of $85.00
BofA Securities downgraded Amphenol from Buy to Neutral and set a new price target of $71.00 from $80.00 previously
Vertical Research initiated coverage of Amphenol with a rating of Hold and set a new price target of $65.00
10-Q - AMPHENOL CORP /DE/ (0000820313) (Filer)
8-K - AMPHENOL CORP /DE/ (0000820313) (Filer)
CERT - AMPHENOL CORP /DE/ (0000820313) (Filer)
Second Quarter 2025 Highlights: Sales of $5.7 billion, up 57% in U.S. dollars and 41% organically compared to the second quarter of 2024 GAAP Diluted EPS of $0.86, up 110% compared to prior year Adjusted Diluted EPS of $0.81, up 84% compared to prior year GAAP and Adjusted Operating Margin of 25.1% and 25.6%, respectively Operating and Free Cash Flow of $1.4 billion and $1.1 billion, respectively Acquired Narda-MITEQ in May Amphenol Corporation (NYSE:APH) today reported record second quarter 2025 results. "We are pleased to have closed the second quarter of 2025 with record sales and Adjusted Diluted EPS, both significantly exceeding the high end of our guidance," sai
Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the second quarter 2025 dividend on its Common Stock in the amount of $0.165 per share at its meeting held on April 30, 2025. The Company will pay this second quarter 2025 dividend on July 9, 2025 to shareholders of record as of June 17, 2025. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 count
First Quarter 2025 Highlights: Record Sales of $4.8 billion, up 48% in U.S. dollars and 33% organically compared to the first quarter of 2024 GAAP Diluted EPS of $0.58, up 32% compared to prior year Record Adjusted Diluted EPS of $0.63, up 58% compared to prior year GAAP and Record Adjusted Operating Margin of 21.3% and 23.5%, respectively Operating and Free Cash Flow of $765 million and $580 million, respectively Completed two acquisitions: LifeSync and CommScope's OWN and DAS businesses Amphenol Corporation (NYSE:APH) today reported record first quarter 2025 results. "We are pleased to have closed the first quarter of 2025 with record sales and Adjusted Diluted EPS, both si
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE:APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial busin